# Betaferon Use in Children and Adolescents With Multiple Sclerosis

> **NCT03577977** · — · COMPLETED · sponsor: **Bayer** · enrollment: 70 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Interferon beta-1b (Betaseron, Betaferon, BAY86-5046)

## Key facts

- **NCT ID:** NCT03577977
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06-01
- **Primary completion:** 2009-04-15
- **Final completion:** 2009-04-15
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2018-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03577977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03577977, "Betaferon Use in Children and Adolescents With Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03577977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*